| ADAMTS | a disintegrin and metalloproteinase with thrombospondin motifs |
| ADME | absorption, distribution, metabolism and excretion |
| AML | acute myelogenous leukemia |
| AOM | azoxymethane |
| Ara C | cytosine arabinoside |
| CAC | colitis-associated cancer |
| CAFs | cancer-associated fibroblasts |
| CAM-DR | cell adhesion-mediated drug resistance |
| Dox | doxorubicin |
| DPPIV | dipeptidyl peptidase IV |
| DSS | dextran sulfate sodium |
| ECM | extracellular matrix |
| eEF | eukaryotic elongation factor |
| EGF | epidermal growth factor |
| ER | estrogen receptor |
| FN | fibronectin |
| GBM | glioblastoma multiforme |
| IBD | inflammatory bowel disease |
| LDV | Leu–Asp–Val |
| MAPK | mitogen-activated protein kinase |
| MCAM | melanoma cellular adhesion molecule |
| MGMT | O6-methylguanine–DNA methyltransferase |
| MIA | melanoma inhibitory activity |
| MMP | matrix metalloproteinase |
| MRD | minimal residual disease |
| OSCC | oral squamous cell carcinoma |
| PDGF | platelet-derived growth factor |
| PDGF-R | platelet-derived growth factor-receptor |
| pFN | plasma fibronectin |
| PD | pharmacodynamics |
| PK | pharmacokinetics |
| RGD | Arg–Gly–Asp |
| SPARC | secreted protein acidic and rich in cysteine |
| TLR | toll-like receptor |
| TME | tumor microenvironment |
| TMZ | temozolomide |
| TNC | tenascin-C |
| UC | ulcerative colitis |
| 5-FU | 5-Fluorouracil |